(Q39690598)

14 September 2017

title

Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells (English)

1 reference

14 September 2017

1 reference

1 reference

Taiki Moriyama

1

1 reference

14 September 2017

Kenoki Ohuchida

2

1 reference

14 September 2017

Kazuhiro Mizumoto

3

1 reference

14 September 2017

Lin Cui

4

1 reference

14 September 2017

Naoki Ikenaga

5

1 reference

14 September 2017

Norihiro Sato

6

1 reference

14 September 2017

Masao Tanaka

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

116

1 reference

14 September 2017

issue

14

1 reference

14 September 2017

page(s)

3357-3368

1 reference

Current status of surgery for pancreatic cancer.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Cancerous stem cells can arise from pediatric brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133, a novel marker for human prostatic epithelial stem cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Identification of pancreatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Pancreatic stellate cells: partners in crime with pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Stem cell marker CD133 affects clinical outcome in glioma patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

CXCR4 expression mediates glioma cell invasiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25121

7 January 2021

Identifiers

DOI

10.1002/CNCR.25121

1 reference

14 September 2017

1 reference